1.32
1.49%
-0.02
After Hours:
1.29
-0.03
-2.27%
Avenue Therapeutics Inc Stock (ATXI) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Research and Development |
143.58%
2.392
|
0.982 | 0.907 | 3.027 | 1.215 |
Operating Income/Loss |
74.99%
-3.708
|
-2.119 | -2.068 | -3.923 | -6.429 |
Nonoperating Income/Loss |
-0.641
|
- | 2.581 | -0.093 | -1.173 |
Income/Loss From Continuing Operations Before Tax |
804.86%
-4.349
|
0.617 | 0.513 | -4.016 | -7.602 |
Income/Loss From Continuing Operations After Tax |
804.86%
-4.349
|
0.617 | 0.513 | -4.016 | -7.602 |
Net Income/Loss
|
804.86%
-4.349
|
0.617 | 0.513 | -4.016 | -7.602 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
60.87%
-0.009
|
-0.023 | -0.013 | -0.009 | -0.066 |
Basic Average Shares |
83.65%
0.562
|
3.4366 | 8.1142 | - | 5.5648 |
Basic Earnings Per Share |
2,850%
-15.40
|
0.56 | 0.06 | -0.52 | -1.35 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):